ZA829408B - Use of peptides as medicament - Google Patents

Use of peptides as medicament

Info

Publication number
ZA829408B
ZA829408B ZA829408A ZA829408A ZA829408B ZA 829408 B ZA829408 B ZA 829408B ZA 829408 A ZA829408 A ZA 829408A ZA 829408 A ZA829408 A ZA 829408A ZA 829408 B ZA829408 B ZA 829408B
Authority
ZA
South Africa
Prior art keywords
peptides
medicament
Prior art date
Application number
ZA829408A
Other languages
English (en)
Inventor
Karin Damm Jorgensen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of ZA829408B publication Critical patent/ZA829408B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA829408A 1981-12-23 1982-12-22 Use of peptides as medicament ZA829408B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK576381 1981-12-23

Publications (1)

Publication Number Publication Date
ZA829408B true ZA829408B (en) 1983-10-26

Family

ID=8145055

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA829408A ZA829408B (en) 1981-12-23 1982-12-22 Use of peptides as medicament

Country Status (11)

Country Link
EP (1) EP0082731A1 (xx)
JP (1) JPS58116421A (xx)
AU (1) AU9188382A (xx)
BE (1) BE895432A (xx)
DE (1) DE3247786A1 (xx)
GB (1) GB2112641A (xx)
GR (1) GR78411B (xx)
IT (1) IT1155438B (xx)
LU (1) LU84546A1 (xx)
NZ (1) NZ202757A (xx)
ZA (1) ZA829408B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849708B1 (en) 1986-05-05 2005-02-01 The General Hospital Corporation Insulinotropic hormone and uses thereof
US7138486B2 (en) 1986-05-05 2006-11-21 The General Hospital Corporation Insulinotropic hormone derivatives and uses thereof
US5614492A (en) * 1986-05-05 1997-03-25 The General Hospital Corporation Insulinotropic hormone GLP-1 (7-36) and uses thereof
JP2583257B2 (ja) * 1986-05-05 1997-02-19 ザ・ジェネラル・ホスピタル・コーポレーション インシュリン向性ホルモン
US5120712A (en) * 1986-05-05 1992-06-09 The General Hospital Corporation Insulinotropic hormone
GB9409496D0 (en) 1994-05-12 1994-06-29 London Health Ass Method for improving glycaemic control in diabetes
US5574008A (en) * 1994-08-30 1996-11-12 Eli Lilly And Company Biologically active fragments of glucagon-like insulinotropic peptide
US5512549A (en) * 1994-10-18 1996-04-30 Eli Lilly And Company Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
DK2158214T3 (da) 2007-06-15 2011-12-05 Zealand Pharma As Glukagonanaloger
EP2025684A1 (en) * 2007-08-15 2009-02-18 Zealand Pharma A/S Glucagon analogues
CN102292347A (zh) 2008-12-15 2011-12-21 西兰制药公司 胰高血糖素类似物
MA32970B1 (fr) 2008-12-15 2012-01-02 Zealand Pharma As Analogues du glucagon
JP5635531B2 (ja) 2008-12-15 2014-12-03 ジーランド ファーマ アクティーゼルスカブ グルカゴン類似体
WO2010070255A1 (en) 2008-12-15 2010-06-24 Zealand Pharma A/S Glucagon analogues
ME02220B (me) 2009-07-13 2016-02-20 Zealand Pharma As Analozi acilovanog glukagona
UY33462A (es) 2010-06-23 2012-01-31 Zealand Pharma As Analogos de glucagon
BR112012033225A2 (pt) 2010-06-24 2017-06-20 Zealand Pharma As análogos do glucagon
US10100097B2 (en) 2012-05-03 2018-10-16 Zealand Pharma A/S GIP-GLP-1 dual agonist compounds and methods
CN104662038B (zh) 2012-07-23 2018-11-06 西兰制药公司 胰高血糖素类似物
TWI608013B (zh) 2012-09-17 2017-12-11 西蘭製藥公司 升糖素類似物
US9988429B2 (en) 2013-10-17 2018-06-05 Zealand Pharma A/S Glucagon analogues
CN105745222A (zh) 2013-10-17 2016-07-06 西兰制药公司 酰化胰高血糖素类似物
TWI670281B (zh) 2013-11-06 2019-09-01 西蘭製藥公司 Gip-glp-1雙重促效劑化合物及方法
CA2929107C (en) 2013-11-06 2023-09-26 Zealand Pharma A/S Glucagon-glp-1-gip triple agonist compounds
ES2883345T3 (es) 2014-10-29 2021-12-07 Zealand Pharma As Compuestos agonistas del GIP y métodos
JP6989385B2 (ja) 2015-04-16 2022-01-05 ジーランド ファーマ アクティーゼルスカブ アシル化グルカゴン類似体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK283180A (da) * 1980-07-01 1982-01-02 Novo Industri As Polypeptider og derivater deraf

Also Published As

Publication number Publication date
IT1155438B (it) 1987-01-28
GB2112641A (en) 1983-07-27
EP0082731A1 (en) 1983-06-29
IT8224915A0 (it) 1982-12-22
AU9188382A (en) 1983-06-30
GR78411B (xx) 1984-09-27
LU84546A1 (de) 1983-09-08
IT8224915A1 (it) 1984-06-22
DE3247786A1 (de) 1983-07-21
BE895432A (fr) 1983-06-21
JPS58116421A (ja) 1983-07-11
NZ202757A (en) 1985-11-08

Similar Documents

Publication Publication Date Title
ZA829408B (en) Use of peptides as medicament
DE3273153D1 (en) Pharmaceutical mixture
ZA848375B (en) Medicament formulation
DE3273948D1 (en) Pharmaceutical preparations
EP0070525A3 (en) Pharmaceutical preparations for external use
GB2116042B (en) Injector for medical uses
DE3264782D1 (en) Medicinal formulation
PH19309A (en) Treatment of aluminous materials
JPS57149230A (en) Medicinal composition
PT75889A (en) Therapeutic agent
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
JPS57198100A (en) Treatment of mollases
GB2119365B (en) Preparation of azinomethyl-rifamycins
JPS57206615A (en) Medicinal composition containing guanfasin
JPS57166993A (en) Preparation of chunicamycin
IL67432A0 (en) Preparation of hetaryloxy-acetamides
PH18457A (en) Pharmaceutical preparations
IL66419A0 (en) Preparation of 4-amino-butyramide
ZA822120B (en) Pharmaceutical preparation
GB8322272D0 (en) Peptides as medicament
IL65060A (en) Preparation of 4-hydroxy-6-methyl-2-pyrone
JPS57153661A (en) Therapeutic container
GB2110676B (en) Preparation of 3-alkoxycycloalk-2-en-1-ones
DE3170230D1 (en) Therapeutic agent
JPS57139070A (en) Medicinal composition